nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.345	0.617	CbGbCtD
Methamphetamine—L-Phenylalanine—Melphalan—peripheral nervous system neoplasm	0.298	1	CrCrCtD
Methamphetamine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.103	0.184	CbGbCtD
Methamphetamine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.102	0.182	CbGbCtD
Methamphetamine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00948	0.0169	CbGbCtD
Methamphetamine—SLC18A2—ganglion—peripheral nervous system neoplasm	0.00231	0.073	CbGeAlD
Methamphetamine—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.00203	0.0526	CcSEcCtD
Methamphetamine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00177	0.0559	CbGeAlD
Methamphetamine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00175	0.0552	CbGeAlD
Methamphetamine—SLC22A3—tongue—peripheral nervous system neoplasm	0.00163	0.0514	CbGeAlD
Methamphetamine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.0016	0.0506	CbGeAlD
Methamphetamine—MAOB—nerve—peripheral nervous system neoplasm	0.00154	0.0487	CbGeAlD
Methamphetamine—MAOB—ganglion—peripheral nervous system neoplasm	0.00152	0.0481	CbGeAlD
Methamphetamine—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.00149	0.584	CrCbGaD
Methamphetamine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00143	0.0451	CbGeAlD
Methamphetamine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00141	0.0445	CbGeAlD
Methamphetamine—MAOA—nerve—peripheral nervous system neoplasm	0.00132	0.0415	CbGeAlD
Methamphetamine—MAOA—ganglion—peripheral nervous system neoplasm	0.0013	0.041	CbGeAlD
Methamphetamine—Euphoric mood—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.0306	CcSEcCtD
Methamphetamine—Euphoric mood—Tretinoin—peripheral nervous system neoplasm	0.00118	0.0306	CcSEcCtD
Methamphetamine—SLC18A2—brainstem—peripheral nervous system neoplasm	0.001	0.0317	CbGeAlD
Methamphetamine—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.000974	0.0253	CcSEcCtD
Methamphetamine—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.000974	0.0253	CcSEcCtD
Methamphetamine—Euphoric mood—Alitretinoin—peripheral nervous system neoplasm	0.000894	0.0232	CcSEcCtD
Methamphetamine—Ephedrine—BCHE—peripheral nervous system neoplasm	0.000823	0.322	CrCbGaD
Methamphetamine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000808	0.0255	CbGeAlD
Methamphetamine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000762	0.0241	CbGeAlD
Methamphetamine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00076	0.024	CbGeAlD
Methamphetamine—MAOB—trigeminal ganglion—peripheral nervous system neoplasm	0.000748	0.0236	CbGeAlD
Methamphetamine—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.000738	0.0192	CcSEcCtD
Methamphetamine—MAOB—parotid gland—peripheral nervous system neoplasm	0.000705	0.0223	CbGeAlD
Methamphetamine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000696	0.022	CbGeAlD
Methamphetamine—MAOB—brainstem—peripheral nervous system neoplasm	0.000662	0.0209	CbGeAlD
Methamphetamine—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.000638	0.0201	CbGeAlD
Methamphetamine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.000614	0.0194	CbGeAlD
Methamphetamine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000613	0.0194	CbGeAlD
Methamphetamine—MAOA—parotid gland—peripheral nervous system neoplasm	0.000602	0.019	CbGeAlD
Methamphetamine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000588	0.0186	CbGeAlD
Methamphetamine—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.00058	0.015	CcSEcCtD
Methamphetamine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000579	0.0183	CbGeAlD
Methamphetamine—MAOA—brainstem—peripheral nervous system neoplasm	0.000565	0.0178	CbGeAlD
Methamphetamine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000563	0.0146	CcSEcCtD
Methamphetamine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000563	0.0146	CcSEcCtD
Methamphetamine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000554	0.0175	CbGeAlD
Methamphetamine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.0143	CcSEcCtD
Methamphetamine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.000552	0.0143	CcSEcCtD
Methamphetamine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000531	0.0138	CcSEcCtD
Methamphetamine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000531	0.0138	CcSEcCtD
Methamphetamine—SLC18A2—cerebellum—peripheral nervous system neoplasm	0.000495	0.0156	CbGeAlD
Methamphetamine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00049	0.0155	CbGeAlD
Methamphetamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000478	0.0124	CcSEcCtD
Methamphetamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000478	0.0124	CcSEcCtD
Methamphetamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000472	0.0123	CcSEcCtD
Methamphetamine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000443	0.0115	CcSEcCtD
Methamphetamine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000443	0.0115	CcSEcCtD
Methamphetamine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000435	0.0113	CcSEcCtD
Methamphetamine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000431	0.0112	CcSEcCtD
Methamphetamine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000431	0.0112	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000426	0.0111	CcSEcCtD
Methamphetamine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.0111	CcSEcCtD
Methamphetamine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000426	0.011	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000423	0.011	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.011	CcSEcCtD
Methamphetamine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000422	0.011	CcSEcCtD
Methamphetamine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000419	0.0109	CcSEcCtD
Methamphetamine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000419	0.0109	CcSEcCtD
Methamphetamine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.0109	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000418	0.0108	CcSEcCtD
Methamphetamine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000403	0.0105	CcSEcCtD
Methamphetamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000402	0.0104	CcSEcCtD
Methamphetamine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000392	0.0102	CcSEcCtD
Methamphetamine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000389	0.0101	CcSEcCtD
Methamphetamine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.0101	CcSEcCtD
Methamphetamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000384	0.00997	CcSEcCtD
Methamphetamine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000375	0.0118	CbGeAlD
Methamphetamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000364	0.00945	CcSEcCtD
Methamphetamine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00943	CcSEcCtD
Methamphetamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00941	CcSEcCtD
Methamphetamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000361	0.00937	CcSEcCtD
Methamphetamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000361	0.00937	CcSEcCtD
Methamphetamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000356	0.00925	CcSEcCtD
Methamphetamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000338	0.00877	CcSEcCtD
Methamphetamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000336	0.00872	CcSEcCtD
Methamphetamine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000336	0.0106	CbGeAlD
Methamphetamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000335	0.0087	CcSEcCtD
Methamphetamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000335	0.0087	CcSEcCtD
Methamphetamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000331	0.00859	CcSEcCtD
Methamphetamine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00848	CcSEcCtD
Methamphetamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000327	0.00848	CcSEcCtD
Methamphetamine—MAOB—cerebellum—peripheral nervous system neoplasm	0.000326	0.0103	CbGeAlD
Methamphetamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000324	0.00841	CcSEcCtD
Methamphetamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000324	0.00841	CcSEcCtD
Methamphetamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000324	0.0084	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.00832	CcSEcCtD
Methamphetamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00824	CcSEcCtD
Methamphetamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000309	0.00803	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000309	0.00802	CcSEcCtD
Methamphetamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00801	CcSEcCtD
Methamphetamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000307	0.00797	CcSEcCtD
Methamphetamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000307	0.00797	CcSEcCtD
Methamphetamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000306	0.00794	CcSEcCtD
Methamphetamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000295	0.00766	CcSEcCtD
Methamphetamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00766	CcSEcCtD
Methamphetamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000283	0.00734	CcSEcCtD
Methamphetamine—MAOA—cerebellum—peripheral nervous system neoplasm	0.000278	0.00879	CbGeAlD
Methamphetamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000274	0.00711	CcSEcCtD
Methamphetamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.0071	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000273	0.00709	CcSEcCtD
Methamphetamine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000268	0.00845	CbGeAlD
Methamphetamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000264	0.00684	CcSEcCtD
Methamphetamine—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000256	0.0081	CbGeAlD
Methamphetamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.00659	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00025	0.0065	CcSEcCtD
Methamphetamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000248	0.00643	CcSEcCtD
Methamphetamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00637	CcSEcCtD
Methamphetamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000245	0.00635	CcSEcCtD
Methamphetamine—Selegiline—ABCB1—peripheral nervous system neoplasm	0.000238	0.0934	CrCbGaD
Methamphetamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000237	0.00614	CcSEcCtD
Methamphetamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000233	0.00605	CcSEcCtD
Methamphetamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00604	CcSEcCtD
Methamphetamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00023	0.00598	CcSEcCtD
Methamphetamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000224	0.00582	CcSEcCtD
Methamphetamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000217	0.00562	CcSEcCtD
Methamphetamine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000214	0.00674	CbGeAlD
Methamphetamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000214	0.00554	CcSEcCtD
Methamphetamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000198	0.00515	CcSEcCtD
Methamphetamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000192	0.00497	CcSEcCtD
Methamphetamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00475	CcSEcCtD
Methamphetamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000182	0.00471	CcSEcCtD
Methamphetamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00457	CcSEcCtD
Methamphetamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00439	CcSEcCtD
Methamphetamine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000165	0.00522	CbGeAlD
Methamphetamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00423	CcSEcCtD
Methamphetamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00412	CcSEcCtD
Methamphetamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00381	CcSEcCtD
Methamphetamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00381	CcSEcCtD
Methamphetamine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00371	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00364	CcSEcCtD
Methamphetamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00361	CcSEcCtD
Methamphetamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00353	CcSEcCtD
Methamphetamine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00343	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00337	CcSEcCtD
Methamphetamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00335	CcSEcCtD
Methamphetamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00334	CcSEcCtD
Methamphetamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00311	CcSEcCtD
Methamphetamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.0031	CcSEcCtD
Methamphetamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00289	CcSEcCtD
Methamphetamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00287	CcSEcCtD
Methamphetamine—ADRA2C—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000108	0.00155	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000108	0.00155	CbGpPWpGaD
Methamphetamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00279	CcSEcCtD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00149	CbGpPWpGaD
Methamphetamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00267	CcSEcCtD
Methamphetamine—MAOB—Metabolism—GNS—peripheral nervous system neoplasm	0.000102	0.00146	CbGpPWpGaD
Methamphetamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00264	CcSEcCtD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000101	0.00145	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000101	0.00145	CbGpPWpGaD
Methamphetamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.00258	CcSEcCtD
Methamphetamine—MAOB—Metabolism—NME1—peripheral nervous system neoplasm	9.77e-05	0.0014	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.66e-05	0.00139	CbGpPWpGaD
Methamphetamine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.00244	CcSEcCtD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	9.42e-05	0.00135	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	9.41e-05	0.00135	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—COX2—peripheral nervous system neoplasm	9.4e-05	0.00135	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	9.18e-05	0.00132	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	9.16e-05	0.00132	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	9.05e-05	0.0013	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.99e-05	0.00129	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.98e-05	0.00129	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.96e-05	0.00129	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.84e-05	0.00127	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	8.77e-05	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.74e-05	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	8.74e-05	0.00126	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GNS—peripheral nervous system neoplasm	8.62e-05	0.00124	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	8.56e-05	0.00123	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.36e-05	0.0012	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NME1—peripheral nervous system neoplasm	8.26e-05	0.00119	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.2e-05	0.00118	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	8.2e-05	0.00118	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.97e-05	0.00115	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—COX2—peripheral nervous system neoplasm	7.95e-05	0.00114	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	7.92e-05	0.00114	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.91e-05	0.00114	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.69e-05	0.00111	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.65e-05	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	7.64e-05	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	7.64e-05	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.44e-05	0.00107	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.32e-05	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.27e-05	0.00105	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.23e-05	0.00104	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.21e-05	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CD55—peripheral nervous system neoplasm	7.13e-05	0.00103	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.09e-05	0.00102	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.07e-05	0.00102	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.99e-05	0.00101	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.98e-05	0.001	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	6.95e-05	0.000999	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IFNB1—peripheral nervous system neoplasm	6.73e-05	0.000968	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.72e-05	0.000966	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	6.66e-05	0.000957	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.65e-05	0.000956	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.52e-05	0.000937	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	6.39e-05	0.000919	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IFNB1—peripheral nervous system neoplasm	6.29e-05	0.000904	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KNG1—peripheral nervous system neoplasm	6.24e-05	0.000897	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.21e-05	0.000893	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.2e-05	0.000892	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.19e-05	0.000891	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ENO2—peripheral nervous system neoplasm	6.17e-05	0.000887	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	6.13e-05	0.000881	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	6.1e-05	0.000877	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	6.04e-05	0.000869	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	6.04e-05	0.000868	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.91e-05	0.000849	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	5.9e-05	0.000848	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KNG1—peripheral nervous system neoplasm	5.83e-05	0.000838	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.8e-05	0.000833	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.7e-05	0.000819	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.7e-05	0.000819	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.64e-05	0.000811	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.63e-05	0.000809	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.57e-05	0.000801	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.52e-05	0.000794	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—GNAS—peripheral nervous system neoplasm	5.45e-05	0.000784	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	5.29e-05	0.000761	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GNS—peripheral nervous system neoplasm	5.26e-05	0.000756	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ENO2—peripheral nervous system neoplasm	5.22e-05	0.000751	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—BCHE—peripheral nervous system neoplasm	5.21e-05	0.00075	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.2e-05	0.000748	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HGF—peripheral nervous system neoplasm	5.2e-05	0.000747	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IFNB1—peripheral nervous system neoplasm	5.11e-05	0.000734	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—GNAS—peripheral nervous system neoplasm	5.1e-05	0.000733	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.06e-05	0.000727	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	5.04e-05	0.000725	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NME1—peripheral nervous system neoplasm	5.04e-05	0.000725	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.98e-05	0.000717	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.97e-05	0.000715	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TH—peripheral nervous system neoplasm	4.9e-05	0.000705	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.89e-05	0.000703	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HGF—peripheral nervous system neoplasm	4.85e-05	0.000698	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—COX2—peripheral nervous system neoplasm	4.85e-05	0.000698	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.75e-05	0.000684	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.75e-05	0.000683	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	4.73e-05	0.000681	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.71e-05	0.000677	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.67e-05	0.000672	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	4.63e-05	0.000665	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.58e-05	0.000659	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.51e-05	0.000649	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	4.41e-05	0.000634	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.4e-05	0.000632	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	4.27e-05	0.000614	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	4.23e-05	0.000608	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.21e-05	0.000606	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.21e-05	0.000605	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	4.15e-05	0.000596	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	4.14e-05	0.000595	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	4.09e-05	0.000589	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	4e-05	0.000575	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.98e-05	0.000572	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	3.94e-05	0.000567	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.94e-05	0.000567	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	3.94e-05	0.000567	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	3.93e-05	0.000565	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	3.87e-05	0.000557	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.85e-05	0.000553	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.79e-05	0.000545	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.7e-05	0.000532	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.69e-05	0.000531	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.68e-05	0.000529	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.58e-05	0.000515	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.57e-05	0.000513	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.57e-05	0.000513	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.54e-05	0.000509	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.48e-05	0.0005	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.45e-05	0.000496	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.42e-05	0.000492	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	3.39e-05	0.000487	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000486	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.35e-05	0.000482	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.34e-05	0.000481	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.33e-05	0.000479	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.32e-05	0.000478	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.29e-05	0.000473	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	3.27e-05	0.00047	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.22e-05	0.000463	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ENO2—peripheral nervous system neoplasm	3.19e-05	0.000458	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.13e-05	0.00045	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.12e-05	0.000449	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TH—peripheral nervous system neoplasm	3.08e-05	0.000442	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.07e-05	0.000442	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.07e-05	0.000442	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	3.05e-05	0.000438	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.99e-05	0.00043	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.92e-05	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.88e-05	0.000414	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.86e-05	0.000411	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	2.83e-05	0.000407	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.81e-05	0.000404	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.78e-05	0.0004	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.72e-05	0.000391	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.71e-05	0.000389	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	2.69e-05	0.000387	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.67e-05	0.000384	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.67e-05	0.000384	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.62e-05	0.000376	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.62e-05	0.000376	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	2.59e-05	0.000372	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	2.57e-05	0.000369	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.57e-05	0.000369	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	2.53e-05	0.000364	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	2.51e-05	0.000361	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.5e-05	0.000359	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.47e-05	0.000355	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	2.46e-05	0.000354	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.38e-05	0.000342	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.31e-05	0.000332	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000328	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	2.19e-05	0.000314	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.18e-05	0.000313	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000312	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.15e-05	0.000309	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	2.13e-05	0.000306	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.11e-05	0.000304	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.09e-05	0.0003	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	2.07e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	2.06e-05	0.000296	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.05e-05	0.000295	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.03e-05	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	2.03e-05	0.000291	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.02e-05	0.00029	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000284	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.88e-05	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.88e-05	0.00027	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.85e-05	0.000266	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.74e-05	0.000251	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.73e-05	0.000249	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000248	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.69e-05	0.000242	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.68e-05	0.000241	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.67e-05	0.00024	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.65e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.65e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.63e-05	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.6e-05	0.000231	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.56e-05	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.53e-05	0.00022	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000212	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.42e-05	0.000205	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000198	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.36e-05	0.000195	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.34e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.32e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.31e-05	0.000188	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.29e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.27e-05	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.22e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.12e-05	0.000161	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000157	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000155	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.02e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.92e-06	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.75e-06	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.57e-06	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.49e-06	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.3e-06	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.22e-06	0.000133	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	9.14e-06	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.94e-06	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.69e-06	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.61e-06	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.45e-06	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.89e-06	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.73e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.71e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.26e-06	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.22e-06	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.2e-06	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.06e-06	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.99e-06	0.000101	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	6.78e-06	9.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.72e-06	9.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.41e-06	9.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.91e-06	8.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.86e-06	8.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.65e-06	8.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	5.58e-06	8.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.52e-06	7.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.46e-06	7.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.28e-06	7.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.99e-06	7.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.66e-06	6.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.53e-06	6.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.48e-06	6.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.29e-06	6.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.79e-06	5.45e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.95e-06	4.24e-05	CbGpPWpGaD
